Cascade Pharmaceuticals, Inc
Clinical trials sponsored by Cascade Pharmaceuticals, Inc, explained in plain language.
-
New pill aims to shrink dangerous liver fat and shed pounds
Disease control Not yet recruitingThis study is testing if a new investigational pill, CS060380, works better than a placebo when added to an approved weight-loss injection (semaglutide) for people who have both a serious fatty liver disease (MASH) and obesity. About 120 adults in China will take either the new p…
Phase: PHASE2 • Sponsor: Cascade Pharmaceuticals, Inc • Aim: Disease control
Last updated Mar 23, 2026 15:15 UTC
-
Scientists test if fatty meals change new Drug's power
Knowledge-focused Not yet recruitingThis early-stage study aims to understand how a high-fat meal and two common medications (rifampicin and itraconazole) affect how the body absorbs and processes a new drug called CS0159. It will involve 32 healthy adult volunteers. The goal is to gather information to help plan s…
Phase: PHASE1 • Sponsor: Cascade Pharmaceuticals, Inc • Aim: Knowledge-focused
Last updated Mar 30, 2026 14:35 UTC